Thermo Fisher Scientific Inc
TMO450.950USD
-19.080-4.05%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
171.71BCap. mercado
27.10P/E TTM
Información de Thermo Fisher Scientific Inc Compañía
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, the Company provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, the Company provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. The Company’s Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
Información de la empresa
Código de la empresaTMO
Nombre de la empresaThermo Fisher Scientific Inc
Fecha de salida a bolsaAug 27, 1980
Fundada en1960
Director ejecutivoMr. Marc N. Casper
Número de empleados125000
Tipo de títulosOrdinary Share
Fin del año fiscalAug 27
Dirección168 Third Avenue
CiudadWALTHAM
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal02451
Teléfono17816221000
Sitio Webhttps://www.thermofisher.com/
Código de la empresaTMO
Fecha de salida a bolsaAug 27, 1980
Fundada en1960
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
172.49K
--
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
72.41K
+0.47%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
30.37K
+26.31%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
17.12K
+74.12%
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
17.03K
+90.54%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
13.86K
-0.12%
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resource Officer, Senior Vice President
Chief Human Resource Officer, Senior Vice President
13.80K
+28.80%
Mr. Michael A. Boxer
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
8.87K
-29.85%
Dr. Tyler Jacks
Dr. Tyler Jacks
Director
Director
8.01K
+4.42%
Ms. Ruby R. Chandy
Ms. Ruby R. Chandy
Independent Director
Independent Director
2.01K
+20.32%
Ver más
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
172.49K
--
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
72.41K
+0.47%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
30.37K
+26.31%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
17.12K
+74.12%
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
17.03K
+90.54%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
13.86K
-0.12%
Desglose de ingresos
Divisa: USDHora de actualización: mié., 2 de abr
Divisa: USDHora de actualización: mié., 2 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Service
17.84B
41.62%
Consumables
17.59B
41.02%
Instruments
7.45B
17.37%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
21.75B
50.74%
Europe
10.86B
25.32%
Asia Pacific
7.96B
18.55%
Other Regions
1.56B
3.64%
Northern America excluded united states
749.00M
1.75%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Service
17.84B
41.62%
Consumables
17.59B
41.02%
Instruments
7.45B
17.37%
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
8.77%
BlackRock Institutional Trust Company, N.A.
4.56%
State Street Global Advisors (US)
4.36%
T. Rowe Price Associates, Inc.
2.74%
Capital World Investors
2.50%
Other
77.07%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
8.77%
BlackRock Institutional Trust Company, N.A.
4.56%
State Street Global Advisors (US)
4.36%
T. Rowe Price Associates, Inc.
2.74%
Capital World Investors
2.50%
Other
77.07%
Tipo
Accionista
Proporción
Investment Advisor
42.48%
Investment Advisor/Hedge Fund
36.91%
Bank and Trust
2.87%
Research Firm
2.84%
Pension Fund
2.56%
Hedge Fund
2.24%
Sovereign Wealth Fund
1.99%
Foundation
0.28%
Family Office
0.21%
Other
7.61%
Participación institucional
Hora de actualización: jue., 20 de feb
Hora de actualización: jue., 20 de feb
Periodo de informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
4272
350.09M
92.79%
-3.93M
2024Q4
4330
349.72M
92.67%
-4.90M
2024Q3
4195
348.49M
91.10%
-6.75M
2024Q2
4169
349.06M
91.37%
-3.26M
2024Q1
4150
346.74M
90.80%
-11.10M
2023Q4
4145
353.49M
91.48%
-3.65M
2023Q3
4035
353.30M
91.43%
-5.83M
2023Q2
4030
357.37M
92.63%
+1.15M
2023Q1
3992
353.61M
91.65%
-5.21M
2022Q4
3961
356.99M
91.02%
-2.42M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
33.08M
8.77%
+201.59K
+0.61%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
17.20M
4.56%
+65.72K
+0.38%
Dec 31, 2024
State Street Global Advisors (US)
16.45M
4.36%
+129.07K
+0.79%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.33M
2.74%
-64.57K
-0.62%
Dec 31, 2024
Capital World Investors
9.43M
2.5%
+104.34K
+1.12%
Dec 31, 2024
Capital Research Global Investors
7.92M
2.1%
-266.96K
-3.26%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.86M
2.08%
+197.44K
+2.58%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
6.05M
1.6%
+483.36K
+8.68%
Dec 31, 2024
Fidelity Management & Research Company LLC
5.69M
1.51%
-1.59M
-21.86%
Dec 31, 2024
JP Morgan Asset Management
5.66M
1.5%
+1.37M
+31.89%
Dec 31, 2024
Ver más
ETF relacionados
Hora de actualización: mié., 2 de abr
Hora de actualización: mié., 2 de abr
Nombre
Proporción
Amplify Weight Loss Drug & Treatment ETF
5.26%
Monarch Blue Chips Core ETF
4.2%
JPMorgan Healthcare Leaders ETF
3.94%
AdvisorShares Focused Equity ETF
3.85%
Honeytree US Equity ETF
3.83%
Invesco Nasdaq Free Cash Flow Achievers ETF
3.75%
Indexperts Quality Earnings Focused ETF
3.74%
Proshares Ultra Health Care
3.73%
Health Care Select Sector SPDR Fund
3.72%
iShares U.S. Healthcare ETF
3.61%
Ver más
Amplify Weight Loss Drug & Treatment ETF
Proporción5.26%
Monarch Blue Chips Core ETF
Proporción4.2%
JPMorgan Healthcare Leaders ETF
Proporción3.94%
AdvisorShares Focused Equity ETF
Proporción3.85%
Honeytree US Equity ETF
Proporción3.83%
Invesco Nasdaq Free Cash Flow Achievers ETF
Proporción3.75%
Indexperts Quality Earnings Focused ETF
Proporción3.74%
Proshares Ultra Health Care
Proporción3.73%
Health Care Select Sector SPDR Fund
Proporción3.72%
iShares U.S. Healthcare ETF
Proporción3.61%
Dividendos
Un total de
2.29B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 19, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 15, 2025
Mar 14, 2025
Nov 07, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
Dec 13, 2024
Jan 15, 2025
Dec 13, 2024
Jul 11, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
Sep 13, 2024
Oct 15, 2024
Sep 13, 2024
May 22, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 15, 2024
Jun 14, 2024
Feb 21, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 15, 2024
Mar 14, 2024
Nov 09, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 16, 2024
Dec 14, 2023
Jul 13, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 13, 2023
Sep 14, 2023
May 24, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 14, 2023
Jun 14, 2023
Feb 22, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Apr 14, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 14, 2023
Mar 14, 2023
Nov 10, 2022
TMO.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 16, 2023 going ex on Dec 14, 2022
Dec 15, 2022
Jan 16, 2023
Dec 14, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
No datos encontrados
Fecha
Tipo
Relación
No datos encontrados